XML 144 R129.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Payments - Summaries of All STI and LTI Performance Rights Granted (Detail) - Share consolidation adjustment [member]
 12 Months Ended
Jun. 30, 2024
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2022
shares
$ / shares
Disclosure of other equity instruments [line items]      
Balance at end of the end fiscal year Number 1,893,081 [1] 1,339,621 3,100,000
Granted during the fiscal year Number 768,311 1,624,499 339,621
Exercised during the fiscal year Number (500,000) (706,173) (1,200,000)
Balance at end of the end fiscal year Number 2,161,392 1,893,081 [1] 1,339,621
Vested and exercisable at end of the fiscal year Number 231,517 0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member]      
Disclosure of other equity instruments [line items]      
Balance at end of the end fiscal year Number 12,130,033 16,769,906 7,563,502
Granted during the fiscal year Number 2,724,868 1,112,334 11,206,404
Exercised during the fiscal year Number (984,366) (5,752,207) (2,000,000)
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 13,870,535 12,130,033 16,769,906
Vested and exercisable at end of the fiscal year Number 3,256,167 0 1,913,502
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | October 3, 2019 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares   $ 0.26 $ 0.26
Balance at end of the end fiscal year Number 0 1,500,000 3,000,000
Granted during the fiscal year Number   0 0
Exercised during the fiscal year Number   (1,500,000) (1,500,000)
Lapsed during the fiscal year Number   0 0
Balance at end of the end fiscal year Number   0 1,500,000
Vested and exercisable at end of the fiscal year Number   0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | November 1, 2019 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares   $ 0.28 $ 0.28
Balance at end of the end fiscal year Number 0 2,400,000 2,400,000
Granted during the fiscal year Number   0 0
Exercised during the fiscal year Number   (2,400,000) 0
Lapsed during the fiscal year Number   0 0
Balance at end of the end fiscal year Number   0 2,400,000
Vested and exercisable at end of the fiscal year Number   0 1,200,000
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | January 2, 2020 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares   $ 0.26 $ 0.26
Balance at end of the end fiscal year Number 0 1,400,000 1,900,000
Granted during the fiscal year Number   0 0
Exercised during the fiscal year Number   (1,400,000) (500,000)
Lapsed during the fiscal year Number   0 0
Balance at end of the end fiscal year Number   0 1,400,000
Vested and exercisable at end of the fiscal year Number   0 450,000
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | October 2, 2020 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares   $ 0.235 $ 0.235
Balance at end of the end fiscal year Number 0 263,502 263,502
Granted during the fiscal year Number   0 0
Exercised during the fiscal year Number   (263,502) 0
Lapsed during the fiscal year Number   0 0
Balance at end of the end fiscal year Number   0 263,502
Vested and exercisable at end of the fiscal year Number   0 263,502
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | October 1, 2021 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.55 $ 0.55 $ 0.55
Balance at end of the end fiscal year Number 17,699 206,404 0
Granted during the fiscal year Number 0 0 206,404
Exercised during the fiscal year Number (17,699) (188,705) 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 0 17,699 206,404
Vested and exercisable at end of the fiscal year Number 0 0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | November 26, 2021 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.49 $ 0.49 $ 0.49
Balance at end of the end fiscal year Number 3,600,000 3,600,000 0
Granted during the fiscal year Number 0 0 3,600,000
Exercised during the fiscal year Number 0 0 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 3,600,000 3,600,000 3,600,000
Vested and exercisable at end of the fiscal year Number 1,200,000 0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | November 26, 2021 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.49 $ 0.49 $ 0.49
Balance at end of the end fiscal year Number 4,500,000 4,500,000 0
Granted during the fiscal year Number 0 0 4,500,000
Exercised during the fiscal year Number 0 0 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 4,500,000 4,500,000 4,500,000
Vested and exercisable at end of the fiscal year Number 1,500,000 0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | November 26, 2021 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.49 $ 0.49 $ 0.49
Balance at end of the end fiscal year Number 2,900,000 2,900,000 0
Granted during the fiscal year Number 0 0 2,900,000
Exercised during the fiscal year Number (966,667) 0 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 1,933,333 2,900,000 2,900,000
Vested and exercisable at end of the fiscal year Number 0 0 0
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | December 16, 2022 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.33 $ 0.33  
Balance at end of the end fiscal year Number 1,112,334 0  
Granted during the fiscal year Number 0 1,112,334  
Exercised during the fiscal year Number 0 0  
Lapsed during the fiscal year Number 0 0  
Balance at end of the end fiscal year Number 1,112,334 1,112,334 0
Vested and exercisable at end of the fiscal year Number 556,167 0  
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | January 31, 2024 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.35    
Balance at end of the end fiscal year Number 0    
Granted during the fiscal year Number 1,343,856    
Exercised during the fiscal year Number 0    
Lapsed during the fiscal year Number 0    
Balance at end of the end fiscal year Number 1,343,856 0  
Vested and exercisable at end of the fiscal year Number 0    
Equity incentive plan [member] | Short term incentives and long term incentives performance rights [member] | January 31, 2024 [member]      
Disclosure of other equity instruments [line items]      
Fair value | $ / shares $ 0.35    
Balance at end of the end fiscal year Number 0    
Granted during the fiscal year Number 1,381,012    
Exercised during the fiscal year Number 0    
Lapsed during the fiscal year Number 0    
Balance at end of the end fiscal year Number 1,381,012 0  
Vested and exercisable at end of the fiscal year Number 0    
[1] The weighted average share price on the exercising date during the financial year 2024 is $0.285.